First Financial Corp’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

First Financial Corp’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-300	Closed	-$1K	–	464
2013 Q3	$1K	Hold	300	–	–	﹤0.01%	447
2013 Q2	$1K	Buy	+300	New	+$527	﹤0.01%	442

Other funds holding GCVRZ

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Allianz Asset Management

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

First Financial Corp's GCVRZ Position: Q4 2013 in Review

First Financial Corp sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2013, closing a stake of 300 shares — an estimated $1K sold.

First Financial Corp first reported a position in GCVRZ in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 130 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2013.

First Financial Corp reported no remaining Sanofi Contingent Value Rights position as of Q4 2013 after selling out during the quarter.
First Financial Corp sold 300 Sanofi Contingent Value Rights shares in Q4 2013, an estimated $1K.
First Financial Corp first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 2 quarters.
First Financial Corp's Sanofi Contingent Value Rights position peaked at $1K in Q3 2013.
130 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2013.

Based on First Financial Corp's 13F filing for Q4 2013, filed 23 Jan 2014.